Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
J Clin Oncol
; 41(25): 4118-4129, 2023 09 01.
Article
en En
| MEDLINE
| ID: mdl-37257143
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Anticuerpos Biespecíficos
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Infant
Idioma:
En
Revista:
J Clin Oncol
Año:
2023
Tipo del documento:
Article